Overview

An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Methamphetamine substance use is common worldwide. No approved pharmacologic treatments for methamphetamine dependence exist. paliperidone are Second generation antipsychotics,and have effects of blocking dopamine2(D2) and 5-hydroxytryptamine 2A(5-HT) receptors neurotransmitters.To determine whether mirtazapine would reduce methamphetamine use among methamphetamine addicts.
Phase:
N/A
Details
Lead Sponsor:
Wei Hao
Treatments:
Methamphetamine
Paliperidone Palmitate